INTRODUCTION {#S1}
============

It has been well recognized that high dietary salt intake impacts obesity and cardiovascular diseases ([@R8]; [@R13]). Hypertension is a predominant consequence of continuous high salt diet ([@R47]). Interestingly, recent studies have also demonstrated that high dietary salt intake promotes autoimmunity via pro-inflammatory responses ([@R2]; [@R35]). Excessive NaCl intake can dampen the innate immune system ([@R23]; [@R34]), as well as promote the differentiation of pathogenic Th17 cells in either *in vitro* ([@R23]; [@R37]; [@R50]) or *in vivo* in experimental autoimmune encephalomyelitis (EAE), a mouse model of the autoimmune disease multiple sclerosis ([@R37]; [@R50]). Clinical and epidemiological studies in accord with these findings indicate that high sodium intake presents a notably positive correlation with increased disease activity in multiple sclerosis and rheumatoid arthritis patients ([@R7]; [@R44]).

Thymus-derived, naturally occurring CD4^+^Foxp3^+^ cells (tTreg) play an essential role in immunologic homeostasis and the prevention of autoimmune diseases ([@R29]). Although tTreg cells have an ideally preventive role in controlling autoimmune diseases with numerous animal models, the therapeutic effects of tTreg on established autoimmune diseases are still unsatisfactory ([@R24]; [@R40]). One of the important reasons is that the phenotype and function of tTreg subset are not stable in the inflammation conditions ([@R59]). We and others have previously reported that tTreg can convert into other T effector cell subsets, such as Th1, Th2, Th17, and Tfh cells, followed by Foxp3 downregulation and reduction of the immunosuppressive function in the presence of pro-inflammatory cytokines *in vitro* and *in vivo* ([@R6]; [@R31]; [@R59]). [@R14] recently provided a new line of evidence that high salt also markedly diminishes the functional activities of tTreg cells, although it did not change Foxp3 expression.

In addition to the tTreg subset, CD4^+^ Treg cells can be induced in the periphery outside of thymus (pTreg) or from conventional non-Treg cells in the presence of transforming growth factor β (TGF-β) and interleukin (IL)-2 with appropriate antigens (iTreg) ([@R1]; [@R55], [@R58]). Both pTreg and iTreg subsets also express Foxp3 and for the most part share the phenotypic and functional features of the tTreg subset ([@R1]; [@R5]; [@R27]). However, the iTreg subset also displays substantial differences with tTreg subset (e.g., iTreg may be stable in the inflammatory conditions) ([@R59]). It is unknown whether high levels of dietary salt also affect the phenotype and function of the iTreg subset.

Here, we report that neither the differentiation nor function of the iTreg subset was affected by physiologically elevated levels of sodium chloride *in vitro*. The iTreg subset that had differentiated *in vitro* was resistant to Th17 and Th1 cell conversion in the presence of high levels of sodium chloride although high salt significantly increased iTreg proliferation. High dietary salt intake also did not change the differentiation and function of pTreg *in vivo*, although it significantly promoted Th17 cell differentiation in both *in vitro* and *in vivo* systems. Conversely, high salt reduced the Foxp3 expression and functionality of tTreg subset *in vitro* and *in vivo*. RNA sequencing (RNA-seq) analyses showed that high levels of dietary salt did not significantly change the gene profiles related to Treg and inflammatory cell signatures. Thus, our data provide evidence for an additional difference between tTreg and iTreg or pTreg subsets, and implies the induced Treg subset can easily adapt to environmental factors. This subset may therefore have advantages in treating patients with autoimmune diseases in the future.

RESULTS {#S2}
=======

Neither Differentiation nor Stability of iTreg Subset Is Affected by High Salt *In vitro* {#S3}
-----------------------------------------------------------------------------------------

As recent studies have demonstrated that high salt conditions promoted Th17 cell differentiation ([@R23]), we sought to determine whether high salt also similarly affects the biological features of iTreg subset. The iTreg differentiation was conducted with a standard protocol as previously described in the presence of different concentrations of NaCl (20--40 mM) with different time points ([@R59]). Foxp3-GFP knock in mice were used to facilitate the Foxp3 identification and expression on the iTreg subset by flow cytometry. The addition of TGF-β dramatically promoted Foxp3 induction, and around 90% of naive CD4^+^ cells became CD4^+^CD25^+^Foxp3^+^ cells, but high salt did not diminish the Foxp3 induction effect ([Figures 1A](#F1){ref-type="fig"} and [1B](#F1){ref-type="fig"}). If any effect was measured, it was that high levels of sodium chloride slightly increased Foxp3 induction ([Figures 1A](#F1){ref-type="fig"} and [1B](#F1){ref-type="fig"}). We observed that high salt expanded total numbers of CD4^+^Foxp3^+^ cells and elevated the mean fluorescence intensity (MFI) of CD25 ([Figure S1](#SD1){ref-type="supplementary-material"}). Additionally, we also induced Th17 cells and observed that the addition of high salt significantly increased Th17 cell differentiation ([Figure S2](#SD1){ref-type="supplementary-material"}), indicating the precursor cells we used responded to high salt.

We then determined whether high salt affects the stability of iTregs that had been induced. We first induced the iTreg subset as shown in [Figures 1A](#F1){ref-type="fig"} and [1B](#F1){ref-type="fig"}, and high salt was then added to cultures for an additional 3--7 days. Either untreated or NaCl-treated iTregs showed no Foxp3 reduction during these days ([Figures 1C](#F1){ref-type="fig"} and [1D](#F1){ref-type="fig"}). As high salt promotes the tTreg subset to secrete interferon gamma (IFNγ) ([@R14]), we also analyzed whether the iTreg subset began to express IFNγ as for the tTreg subset when they encountered high salt. The iTreg subset did not produce relevant cytokines including IFN-γ and IL-17A and was almost completely resistant to Th1 and Th17 conversion even in the presence of high salt ([Figure 1E](#F1){ref-type="fig"}).

High Salt Has Little Effect on Suppressive Function of iTregs *In vitro* {#S4}
------------------------------------------------------------------------

High salt does not reduce Foxp3 expression but diminishes tTreg functionality ([@R14]). We examined whether high salt also affects the functionality of iTreg subset. A standard *in vitro* co-culture suppression assay was used to study iTreg *in vitro* functionality in the presence or absence of high-salt conditions. Splenic enriched T cells from normal C57BL/6 mice labeled with carboxyfluorescein succinimidyl ester (CFSE) were cultured with γ-irradiated antigen-presenting cells (APC) and with anti-CD3 antibody in the absence or presence of iTregs with or without addition of sodium chloride. T cell proliferation was determined by the CFSE dilution rates after 3 days of culture. There was no obvious proliferation difference of T responders between normal media and with addition of physiologically relevant 20 mM or 40 mM NaCl ([Figure 2A](#F2){ref-type="fig"}). When iTreg (with different ratios) were added to T responder cells, T cell proliferation was remarkably inhibited and exhibited a dose-dependent effect ([Figures 2A](#F2){ref-type="fig"} and [2B](#F2){ref-type="fig"}).

To exclude the possibility that the time of exposure was insufficient for priming iTreg subset with high salt, we pretreated iTreg with high salt for 3 days and then tested their functional activities as described in [Figure 2A](#F2){ref-type="fig"}. The suppressive ability of iTreg pretreated with high salt was similar to the iTreg that had been cocultured with high salt ([Figure 2C](#F2){ref-type="fig"}). This result was consistent under the conditions of different ratios of iTreg and T responder cells ([Figure 2D](#F2){ref-type="fig"}).

High-Salt Primed iTregs Rescue T Cell-Induced Colitis *In vivo* {#S5}
---------------------------------------------------------------

The different effects of high-salt on tTreg and iTreg subsets *in vitro* prompted us to further study whether the iTreg subset is still resistant to high salt *in vivo*. We used a colitis model to validate this possibility. As described previously ([@R4]), CD4^+^CD25^−^CD62L^+^CD44^−^ naive T cells from C57BL/6 mice were transferred into Rag1^−/−^ mice, developing a typical autoimmune intestinal inflammation. Mice gradually lost weight and showed lethargy, piloerection, hunching, and dehydration with a clinical score 2--3 ([Figures 3A](#F3){ref-type="fig"} and [3B](#F3){ref-type="fig"}). However, when iTreg or high salt-primed iTreg were co-transferred into Rag1^−/−^ mice, body weight improved dramatically; meanwhile, adoptive transfer of high salt-treated iTreg had the same effect on controlling the progress of colitis as normal iTreg ([Figure 3A](#F3){ref-type="fig"} and [3B](#F3){ref-type="fig"}). Additionally, splenomegaly, intestine swelling colon length, and shaped stool are proven to be useful indicators of the severity of colitis ([@R4]; [@R14]). Our results showed that model mice had significantly swollen colons, obvious splenomegaly, and less shaped stool compared with iTreg-treated mice. Similarly, high salt-treated iTreg can also markedly alleviate these typical features as normal iTreg, and this was consistent with weight gain ([Figures 3C](#F3){ref-type="fig"} and [3D](#F3){ref-type="fig"}). Histologically, colitis mice showed mucosal ulceration, with loss of the normal crypt structure and intense goblet cell depletion, together with obvious inflammatory cell infiltration and edema. Matching the above data, no matter whether modified by high salt or not, iTreg identically lowered the pathological index ([Figures 3E](#F3){ref-type="fig"} and [3F](#F3){ref-type="fig"}). In an additional experiment, we also observed that the iTreg subset maintained a suppressive effect on colitis when mice were fed a high salt diet (HSD) ([Figure S3A](#SD1){ref-type="supplementary-material"}). Thus, we have further confirmed that iTreg can strongly inhibit T cell-induced colitis, and high salt does not compromise iTreg *in vivo* function.

iTreg Subset Primed with or without High Salt Similarly Restrict Inflammatory Responses and Prevent T Cell Migration to the Inflamed Colon {#S6}
------------------------------------------------------------------------------------------------------------------------------------------

Given that Th17 and Th1 cells play an important role in the pathogenesis of colitis ([@R3]), we also analyzed the frequency of these pathogenic cells in lamina propria (LP), spleens (SP), and mesenteric lymph nodes (mLN) at 6 weeks after cell transfer under different interventions. In line with previous reports, substantial amounts of Th17 and Th1 cells were identified in spleens and mesenteric lymph nodes in Rag1^−/−^ mice when naive CD4^+^ cells were transferred. Co-transfer of iTreg or iTreg that had been pretreated with high salt significantly but similarly inhibited the Th17 and Th1 production in spleens and Th17 production in mLN ([Figures 4A](#F4){ref-type="fig"} and [4B](#F4){ref-type="fig"}). The percentages and total CD4^+^ cells in LP were lowered to a greater extent in both Treg infusion groups than in the colitis control group, suggesting that either iTreg or iTreg pretreated with high salt dramatically and similarly suppressed the migration of CD4^+^ pathogenic cells to the lamina propria ([Figures 4C](#F4){ref-type="fig"} and [4D](#F4){ref-type="fig"}).

Treg subset functionality is usually associated with Foxp3 expression ([@R49]). We also studied the *in vivo* Foxp3 stability of these iTreg subsets pretreated with or without high salt in the colitis model. As shown in [Figures 4E](#F4){ref-type="fig"} and [4F](#F4){ref-type="fig"}, about 35% of Foxp3 (range from 65% to 30%) was maintained at 6 weeks after iTreg transfer, the Foxp3 was similarly sustained on the iTreg subset that had been pretreated with high salt. High salt also did not promote their conversion to Th1 and/or Th17 cells ([Figures S3B](#SD1){ref-type="supplementary-material"}--[S3D](#SD1){ref-type="supplementary-material"}). Additionally, we also observed no difference of Foxp3 expression in colitis or in colitis mice fed with a high salt diet ([Figures 4E](#F4){ref-type="fig"} and [4F](#F4){ref-type="fig"}), suggesting that high salt did not change the transferred iTreg subset stability *in vivo*.

In order to explore the possible mechanisms whereby high salt does not change iTreg subset function, we performed a RNA-seq analysis. Purified iTreg subset was restimulated with anti-CD3/CD28 microbeads in the presence of IL-2 with or without high salt for 72 h, and mRNA expression was determined using RNA-seq ([Figure S4A](#SD1){ref-type="supplementary-material"}). Apart from CCR-6, which was increased around 2.5-fold, almost all mRNA signatures related to immunoregulation and inflammation features of Treg cells are not changed. High salt slightly increased cd274, nt5e, il10, nrp1, and tigit that are related to Treg cell phenotype and function, although it slightly reduced Foxp3 and TGF-β ([Figures S4A](#SD1){ref-type="supplementary-material"} and [S4B](#SD1){ref-type="supplementary-material"}). High salt did not significantly change the levels of Th1, Th2, and Tfh transcripts but somewhat decreased IL-17a and IL-17f, consistent with the stability of the iTreg subset *in vitro* and *in vivo*, as shown in [Figure 5B](#F5){ref-type="fig"}.

SGK1 serves as a critical node in high salt-driving Th17 induction due to prominent IL-17 production, which is also responsible for high salt-mediated loss of suppression in the tTreg subset. It is notable that NaCl-primed iTregs also had slightly elevated SGK1 expression ([Figure S4B](#SD1){ref-type="supplementary-material"}), and although SGK1 was upregulated in both tTreg and iTreg subsets following high salt priming, the functional consequences in both Treg subsets were different.

FOXO proteins are the chief downstream targets of SGK1, which functions in a Treg cell-intrinsic manner to regulate Foxp3 expression of T regulatory cells. SGK1 is known to inactivate both FOXO1 and FXO3a, two main members of the FOXO protein family, to indirectly reduce tTreg cell activities ([@R39]). In fact, a recent study has demonstrated an increase of phosphorylation of FOXO1/FOXO3a in tTreg subset under high salt conditions ([@R14]). Interestingly, we did not observe an increase but found a decrease in phosphorylation of FoxO1/FoxO3a in iTreg subset with the high-salt condition ([Figures S4C](#SD1){ref-type="supplementary-material"} and [S4D](#SD1){ref-type="supplementary-material"}).

Sodium Chloride Reverts the Suppressive Function of Naturally Occurring tTreg Cells but Not iTreg and pTreg Cells *In vitro* and *In vivo* {#S7}
------------------------------------------------------------------------------------------------------------------------------------------

To exclude the possibility that the different stability and functionality of the tTreg subset reported by others could be attributed to subtle methodological differences, we designed a face-to-face comparison experiment where both tTreg and iTreg subsets were simultaneously analyzed for their phenotype and functionality under a high salt environment. An *in vitro* experiment was similarly conducted as in [Figure 2A](#F2){ref-type="fig"}, and showed that both tTreg and iTreg cells similarly suppressed the proliferation of CD8^+^ T responder cells; tTreg pretreated with NaCl significantly diminished their inhibitory activity, while iTreg pretreated with high salt maintained their suppressive ability ([Figures 5A](#F5){ref-type="fig"} and [5B](#F5){ref-type="fig"}). A similar result was also observed when high salt was added to cell cultures (data not shown). We then used colitis models to further confirm that high salt subverted the therapeutic effect of tTreg on colitis, while the effect of the iTreg subset on colitis was sustained even if they had been pretreated with high salt ([Figures 5C](#F5){ref-type="fig"} and [5D](#F5){ref-type="fig"}). We further analyzed their Foxp3 expression during colitis. In these experiments, we co-transferred CD90.1^+^ tTreg or iTreg subsets and CD90.2^+^ naive CD4^+^ cells into Rag1^−/−^ mice to identify the biological features of Treg subsets during colitis. At 5 weeks after cell transfer, we found similar levels of Foxp3^+^ donor cells in both tTreg and iTreg subsets in colitis. However, tTreg cells pretreated with high salt significantly reduced their Foxp3 level ([Figures 5E](#F5){ref-type="fig"} and [5F](#F5){ref-type="fig"}). Conversely, the iTreg subset had no such change on the Foxp3 expression during colitis ([Figures 5E](#F5){ref-type="fig"} and [5F](#F5){ref-type="fig"}). These results further validate that both Treg subsets have different biological characteristics in the high salt condition.

High-Salt Does Not Significantly Affect the Development and Function of iTreg Cells in Humans {#S8}
---------------------------------------------------------------------------------------------

To consider the clinical relevance of our findings, we extended this study from mouse cells to human cells. Although a difference between mouse and human iTreg cell development appears to exist, recent studies have demonstrated that the addition of *all-trans* retinoic acid permits induction of human iTreg in the presence of TGF-β ([@R32]). Using this protocol, we found that the human naive CD4^+^ cells differentiated into Foxp3^+^ cells that have displayed potent *in vitro* suppression. Interestingly, neither the differentiation nor function of human iTreg cells was reduced by high salt exposure ([Figure 6](#F6){ref-type="fig"}). Thus, the human iTreg subset may be also resistant to high salt.

DISCUSSION {#S9}
==========

Although sodium is an indispensable nutrient and is crucial for cellular function in appropriate amounts, high intake of sodium chloride has wide-ranging effects in renal, cardiovascular, and endocrine diseases ([@R2]). Interestingly, recent studies have also demonstrated that a high salt diet promotes the onset of multiple sclerosis and other related autoimmune diseases ([@R25]; [@R61]), raising the possibility that high salt affects the immune system.

Initial studies revealed that excessive sodium chloride uptake mainly affects the innate immune system. [@R34] revealed that a high salt diet stimulates macrophages to secrete vascular endothelial growth factor-C to promote inflammation and hypertension. [@R53] reported that high salt increased pro-inflammatory signatures and decreased anti-inflammatory and pro-endocytic molecules in both human and mouse macrophages, eventually leading to inflammation. Subsequent studies provided evidence that high salt also affects the adaptive immune system. Indeed, high salt promotes Th17 cells and aggravates Th17-mediated inflammation and diseases ([@R23]).

In addition to pro-inflammatory cells and T effector cells, T regulatory cells (Treg) are an integral component of the normal immune system and contribute to the maintenance of peripheral tolerance, which can downregulate immune responses and are essential for immune homeostasis ([@R17]; [@R26]). Although many Treg subsets have been identified, CD4^+^Foxp3^+^ Treg cells are the most important population. These are naturally occurring and develop in the thymus, and therefore are named natural Treg (tTreg) cells ([@R1]; [@R41]; [@R43]). Although the tTreg cell subset has a potent preventive role in inflammatory diseases, the therapeutic effect of tTreg on established disease is less satisfactory and related to their stability ([@R33]; [@R51]; [@R59]; [@R60]). When the diseases are established, pro-inflammatory cytokines can reduce Foxp3 expression and diminish Treg function. Interestingly, the high salt environment also dramatically diminishes the Treg functionality. Although high salt does not reduce Foxp3 expression and change epigenetic marks, high salt promotes tTreg to convert into aTh1-like phenotype with loss of suppressive activity ([@R14]). However, others have also reported that tTreg cells are notably stable under physiologic and inflammatory conditions in an animal model ([@R38]). The possible explanation for this difference is that they have used a Th1 inflammation model, whereas our group and others have previously observed that IL-6 and IL-21 rather than IFNγ are crucial pro-inflammatory cytokines to make this conversion ([@R33]; [@R51]; [@R59]; [@R60]).

Our group first reported that CD4^+^ Treg cells can be induced from the conventional non-Treg cells and this subset has been named induced Treg (iTreg) ([@R55]). iTreg subset shares phenotypic characteristics and suppressive activity of tTreg subset ([@R18]; [@R56], [@R57], [@R58]), however, some differences have been identified between both subsets. For example, the tTreg subset suppresses immune responses mainly through cell contact although they can also produce TGF-β and IL-10, while the iTreg suppresses in a "classical" contact-dependent manner, as well as by cytokines like TGF-β and IL-10 ([@R56], [@R57]). Both tTreg and iTreg subsets directly suppress B cell responses but their mechanisms of action are completely different ([@R20]; [@R52]; [@R54]). While tTreg failed to suppress Th17-mediated disease, the iTreg subset can suppress Th17-mediated disease ([@R19]). Indeed, inflammatory cytokines such as IL-6 and transforming growth factor α (TNF-α) reduce Foxp3 expression and the function of the tTreg subset ([@R10]; [@R51]; [@R59]), nonetheless, the iTreg subset seems to be resistant to these pro-inflammatory cytokines ([@R36]; [@R59]). In addition to the two Treg subsets described above, others also suggest existence of a third population of Treg cell differentiation *in vivo* and named them the pTreg subset ([@R1]). As pTreg cells at least contaminate the tTreg subset that has immigrated from thymus, this classification needs further study ([@R21]; [@R42]).

However, there is also a controversial argument on the stability of iTreg cells induced *ex vivo*. Several groups considered the iTreg subset to be unstable because they observed Foxp3 in conserved non-coding DNA sequence (CNS) elements is methylated in iTreg but not in tTreg subset ([@R9]; [@R12]; [@R22]). There are some reasons that can explain this difference. First, it is not surprising the Foxp3 is turned off in iTreg subset *in vitro* because these cells are differentiated *ex vivo* with short-term exposure of TGF-β. However, continuous exposure of low doses of IL-2 and/or TGF-β can sustain Foxp3 expression ([@R58]). Second, Foxp3 methylation in CNS is not the only factor that affects Treg function. Many studies have demonstrated iTreg subset can prevent and even treat autoimmune diseases although they could be methylated in Foxp3 CNS. Our previous study also demonstrated that all-*trans* retinoic acid (atRA) enhances the quantity and quality of development of iTregs, however, atRA significantly increased histone acetylation within the promoter and conserved non-coding DNA sequence (CNS) elements at the Foxp3 gene locus, while DNA methylation in the CNS was not significantly altered ([@R30]; [@R33]). Third, iTreg stability mostly depends upon the methods by which they are induced. When high levels of TCR stimulation were used, Foxp3 expression occurs rapidly but is not easily sustained ([@R24]), however, suboptimal TCR stimulation and appropriate doses of IL-2 can overcome this problem ([@R11]; [@R58]). Fourth, Foxp3 is not the only factor that contributes to Treg function. Some reports show that cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) plays an important role in T cell-mediated dominant immunologic self-tolerance ([@R45]; [@R48]), and CTLA-4 could function in the Foxp3-independent non-Treg compartment ([@R46]). Others have also observed protective human TGF-β-iTregs that exhibit methylated Foxp3 ([@R15]). Moreover, CD103^+^ iTreg suppress immune responses independent of Foxp3 expression ([@R28]). Furthermore, high salt did not affect Foxp3 level but did reduce its function ([@R14]). Our previous work also demonstrated that iTreg exert their suppressive activity through releasing active TGF-β and IL-10 ([@R16]; [@R56]).

Now, we provide an important line of evidence that the iTreg subset may be more adaptable to environmental change. Our results reveal that a high salt did not affect the development and function of iTreg cell in both mouse and human cells *in vitro*. High salt also does not reduce the differentiation and functionality of the iTreg subset in the mouse *in vivo*. Additionally, high salt does not promote the iTreg subset to convert into Th1- or Th17-like cells, displaying a complete difference between iTreg and tTreg subsets. This cannot be explained by the nonresponse of CD4^+^ cells to high salt, because high salt promoted Th17 cell differentiation, and RNA-seq displayed the changed RNA signatures of high salt-primed CD4^+^ cells.

SGK1 activation leads to downstream phosphorylation of FoxO1/FoxO3a, resulting in Foxp3 degradation and reduction of Treg stability ([@R14]). Interestingly, pFoxO1 expression by the iTreg subset is not increased as in the tTreg subset when exposed to high salt in this study. In fact, high salt even decreases pFoxO1, and thus high salt probably increases the functional activity of the iTreg subset in the high salt environment. The mechanisms of different responses of tTreg and iTreg subsets to high salt deserves further study. However, the high salt diet has significantly promoted disease activity in autoimmune and inflammatory conditions, so it is likely that high salt mainly promotes the activities of macrophages and T effector cells, including Th17 cells, and interferes with function of tTreg subsets ([@R50]; [@R53]).

Taken together, our findings add further evidence to show that TGF-β-induced CD4^+^Foxp3^+^ regulatory T cells are somehow different from natural CD4^+^Foxp3^+^ regulatory T cells, not only in the pro-inflammatory milieu, but also in high salt conditions. Thus, manipulation of iTreg as therapy may provide a superior approach to combat autoimmune and inflammatory diseases in complicated environmental conditions.

STAR★METHODS {#S10}
============

CONTACT FOR REAGENT AND RESOURCE SHARING {#S11}
----------------------------------------

Further information and requests for resources and reagents should be addressed to and will be fulfilled by the Lead Contact, Song Guo Zheng (<szheng1@pennstatehealth.psu.edu>).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S12}
--------------------------------------

### Animals and donors {#S13}

C57BL/6 (B6), C57BL/6-Foxp3^GFP^ and B6 Rag1^−/−^ mice were purchased from Jackson Laboratory. All mice were maintained in a single specific pathogen-free room in the animal facility at the Sun Yat-sen University or the Penn State Hershey College of Medicine. Sex-matched 6- to 12-week-old mice were used in all experiments. All the experimental procedures were approved by the Sun Yat-sen University and the Penn State Hershey College of Medicine Institutional Animal Care and Use Committee. All protocols that involved healthy human blood donors were approved by the third affiliated hospital at Sun Yat-Sen University. Informed consent was obtained from recruited healthy volunteers.

METHOD DETAILS {#S14}
--------------

### *In vitro* polarization and proliferation {#S15}

tTregs were sorted from thymus in C57BL/6 mice or Foxp3^GFP^ C57BL/6 mice by gating on CD4^+^CD25^high^ or CD4^+^GFP^+^ cells. tTregs cells were stimulated with anti-CD3/CD28 microbeads (1 bead: 5 cells; GIBCO) and IL-2 (50 U/ml; R&D) in the presence or absence of high salt (NaCl 40mM) for 3 to 7 days. IL-2 was renewed every other day. The percentage of Foxp3 was examined by flow cytometry. Naive CD4^+^CD25^−^CD62L^+^ CD44^−^ T cells were isolated from spleen cells of C57BL/6 and C57BL/6 Foxp3^GFP^ mice using naive CD4^+^ T cell isolation kit (Miltenyi Biotec, Auburn, CA). Naive cells were \> 95% pure as verified by CD4-Percp-Cy5.5, CD25-PE and CD62L-APC. To generate CD4^+^ induced regulatory T cells (iTregs), naive CD4^+^ cells (3 × 10^5^) were cultured in 96-well plates and stimulated with anti-CD3/CD28 microbeads (5 cells per bead, GIBCO), IL-2 (50 U/ml; R&D) ± TGF-β (2 ng/ml; R&D) for 3 days in X-VIVO 15 medium (LONZA) in the presence or absence of an additional 20 or 40 mM NaCl (Sigma-Aldrich). For iTreg cells proliferation, iTregs were differentiated from naive CD4^+^ T cells, then removed beads, washed the cells, and re-stimulated with anti-CD3/CD28 microbeads (5 cells per bead) in fresh standard media with or without additional of NaCl for another 3 days. Cells were harvested for intracellular staining of IL-17A and IFNγ.

### Suppression assay *in vitro* {#S16}

To examine the suppressive activity of iTregs and tTreg as described in [@R56], enriched T cells (3 × 10^5^) were stained with carboxyfluorescein succinimidyl ester (CFSE) at 2 μM and cultured with Treg subsets at various ratios as indicated. Cells mixtures were stimulated with soluble anti-CD3 (0.025 μg/ml) in the presence of APCs with or without an additional 40 mM NaCl for 3 days and analyzed by FACS. In addition, both Treg subsets were pre-incubated with or without NaCl (40 mM) in the presence of anti-CD3/CD28 microbeads (5 cells per bead), IL-2 (50 U/ml) for 3 days and then washed the cells. These iTregs were re-cultured with CFSE-T cells for an additional three days. The proliferative levels of CFSE-CD8^+^ cells were judged by the rates and intensity of CFSE dilution measured with flow cytometry.

### Generation of human iTregs *ex vivo* {#S17}

Human PBMCs were prepared from heparinized venous blood by Ficoll- Hypaque density gradient centrifugation. CD4^+^CD25^−^CD45RA^+^CD45RO^−^ T cells were sorted from PBMCs (\> 98% purity). These cells (2×10^5^) were cultured in 96-well plates and stimulated with anti-human CD3/CD28 beads (10 cells per bead), rhIL-2 (50 U/ml; R&D Systems) and rhTGF-β (5 ng/ml) in X-VIVO 15 medium (LONZA) in the presence or absence of an additional 20 or 40 mM NaCl (Sigma-Aldrich) for 5 days. Foxp3 expression was determined by flow cytometry assay. The human iTreg suppression assay was similarly assessed as described above.

### Flow cytometry {#S18}

The following fluorescence conjugated mouse antibodies were used for flow cytometric analysis from Biolegend (San Diego, CA): Percp-Cy5.5-CD4 (GK1.5), PE-CD25 (PC61), PE-CD62L (MEL-14). Cell subsets were stained with mAbs and isotype control indicated above, and analyzed on a FACS Calibur flow cytometer. For intracellular staining of cytokines, cells were stimulated with PMA (0.25 μg/ml), ionomycin (0.25 μg/ml) for five hours and brefeldinA (5 μg/ml) for four hours at 37°C, and then permeabilized and stained with IFNγ (XMG1.2) and IL-17A (TC11--18H10.1) antibodies. Data were acquired on FACS and analyzed with flowJo software.

### Mice; adoptive transfer colitis {#S19}

For T cell-induced colitis, methods were followed as outlined previously ([@R4]). iTreg and tTreg subsets were prepared from CD90.1^+^ Foxp3^GFP^ mice. Naive CD4^+^ (CD90.2^+^CD4^+^CD25^−^CD62L^+^CD44^−^) cells from C57BL/6 mice alone or together with CD90.1^+^ iTregs or tTregs (with or without 40 mM NaCl pretreatment) were adoptively transferred into Rag1^−/−^ mice, and weight loss was monitored. The mice were killed at 5 or 6 weeks after the cell transfer, and analyzed for disease severity as described ([@R14]).

### RNA-seq {#S20}

Total RNA was extracted with the RNeasy mini kit (QIAGEN). The RNA degradation and contamination was monitored on 1% agarose gels, and its quality were assessed using the NanoPhotometer spectrophotometer (IMPLEN) and RNA Nano 6000 Assay Kit of the Bioanalyzer 2100 system (Agilent Technologies). cDNA library construction and Illumina sequencing were completed by Beijing Novogene Bioinformatics Technology Co., Ltd. Briefly, sequencing libraries were generated using NEBNext Ultra RNA Library Prep Kit following manufacturer's recommendations. PCR products were purified (AMPure XP system) and library quality was assessed on the Agilent Bioanalyzer 2100 system. The library preparations were sequenced on Illumina Hiseq 2000 platform, and 125 bp/150 bp paired-end reads were generated.

### Western Blotting {#S21}

iTreg cells were re-stimulated with anti-CD3/CD28 microbeads (5 cells per bead) and IL-2 (50 U/ml) and culture for indicated times prior to being harvested. Anti-GAPDH (\#5174) and anti-phospho-FoxO1(Thr24)/FoxO3a (Thr32) (\#9464) were obtained from Cell Signaling Technology. Primary antibodies were detected by secondary anti-rabbit-HRP conjugated (\#7074, Cell Signaling Technology) antibodies.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S22}
---------------------------------------

Statistical analysis was performed using GraphPad Prism (GraphPad Software). Data were analyzed by Student's t test in case of two groups and one-way ANOVA analysis was performed for three and more groups in mice studies. Data are presented if not indicated elsewhere as Mean ± SEM. A value of p \< 0.05 was considered to be statistically significant (\*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001; ns, not significant).
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![High-Salt Condition Does Not Influence Foxp3 Expression and Conversion of iTregs *In vitro*\
Naive CD4^+^ T cells from C57BL/6 mice were stimulated with anti-CD3/28 microbeads in the presence of IL-2 ± TGF-β in standard media, or with additional 20 or 40 mM NaCl for 3 days. Some iTregs were generated normally, harvested, and thoroughly washed on day 3, then renewed either in normal media or media enriched with 20 or 40 mM NaCl for an additional 3 to 7 days with anti-CD3/28 microbeads (5 cells per bead) and IL-2 (50 U/mL).\
(A) Naive CD4^+^ T cells were differentiated into iTregs in the presence or absence of additional 20 or 40 mM NaCl for 3 days and detected by FACS for GFP-Foxp3^+^.\
(B) The line graph depicts a summary of experiments (n = 6).\
(C) Cells were stimulated as in (A) and were re-stimulated under the indicated increased NaCl concentrations for another 3--7 days and analyzed by fluorescence-activated cell sorting (FACS) (one representative experiment of six is shown).\
(D) The line graph depicts a summary of experiments.\
(E) iTregs were re-stimulated under 40 mM NaCl for 3 days and analyzed by flow cytometry for IL-17A and IFNγ. The bar graph depicts a summary of independent experiments (n = 6). Statistical analyses were performed using one-way ANOVA. ns, not significant.](nihms-1521871-f0002){#F1}

![Both Fresh iTreg and NaCl-Primed iTregs Possess Suppressive Function *In vitro*\
(A) Enriched T cells (T~eff~) were labeled with CFSE, stimulated with soluble anti-CD3, and cultured alone or cocultured with iTregs at various ratios as indicated. The culture system was either in normal media or with indicated increased NaCl concentrations. Baseline indicates no added conditioned iTregs. CFSE dilution was detected by FACS after 3 days. Histograms depict cellular proliferation and are gated on CD8^+^ cells.\
(B) The line graph depicts a summary of experiments at iTreg to T~eff~ ratios as indicated (n = 5).\
(C) Naive CD4 cells were differentiated into Tregs as described in [STAR Methods](#S10){ref-type="sec"}, then re-stimulated under the indicated increased NaCl concentrations for another 3 days. Following incubation, iTregs were washed, counted and plated in a suppression assay in normal media as in (A). CFSE dilution was detected by FACS after 3 days. Histograms depict cellular proliferation and are gated on CD8^+^ cells.\
(D) The line graph depicts a summary of experiments at iTreg to T~eff~ ratios as indicated (n = 5).](nihms-1521871-f0003){#F2}

![Immunosuppressive Activity of NaCl-Primed or Normal iTregs *In vivo* Is Similar *In vitro* When Assessed in the Rag1^−/−^ Mice Inflammatory Bowel Disease Model\
iTregs were prepared from CD90.1^+^ Foxp3^−^GFP knock-in mice. Naive CD4^+^ (CD90.2^+^CD4^+^CD25^−^CD62L^+^CD44^−^) cells from C57BL/6 mice alone or together with CD90.1^+^ iTregs were adoptively transferred into Rag1^−/−^ mice intraperitoneally (i.p.). The mice were killed at 6 weeks after the cell transfer and analyzed for disease severity (6 mice in each group in one experiment).\
(A) Body weight of the recipient mice was presented as a percentage of the initial weight.\
(B) Average clinical scores of each group are shown.\
(C) Gross morphology of colons and spleens are shown.\
(D) Absolute numbers of total splenocytes were compared.\
(E) H&E staining of colon sections. Scale bars, 100 μm. Representative results (mean ± SEM) from four independent experiments are shown.\
(F) Histological score. Statistical analyses were performed using one-way ANOVA between respective dietary and adoptive transfer groups. \*p \< 0.05. \*\*p \< 0.01. ns, not significant.](nihms-1521871-f0004){#F3}

![NaCl-Primed or Normal iTregs Inhibit Differentiation of Pathogenic Cells in Inflammatory Colitis and Prevent Pathogenic Cells from Infiltrating to Colon\
(A) Colitis mice were sacrificed at 6 weeks after cell administration, and CD4^+^ cells from the spleen (SP) and mesenteric lymph nodes (mLN) were examined. Flow cytometric analysis and frequencies of IL-17A^+^CD90.2^+^ and IFNγ^+^CD90.2^+^ cells were examined in the respective mouse groups (6 mice in each group in one experiment).\
(B) The bar graph depicts a summary of the experiment (6 mice in each group in one experiment).\
(C) The infiltrating cells in large intestines (LP) were analyzed on total CD4^+^ T cells.\
(D) The bar graph depicts a summary of the experiment (6 mice in each group in one experiment).\
(E) On day 35 and 45 after cells transfer, iTreg^−^ Foxp3 loss were compared in SP and LN, cells were gated on CD90.1^+^. Representative results (mean ± SEM) from four independent experiments are shown.\
(F) The line graph depicts a summary of the experiment (6 mice in each group in one experiment). Statistical analyses were performed using one-way ANOVA. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001; ns, not significant.](nihms-1521871-f0005){#F4}

![Sodium Chloride Reverts the Suppressive Function of Naturally Occurring Treg Cells but Not TGF-β-Induced Treg Cells *In vitro* and *In vivo*\
(A) tTregs isolated from thymus and TGF-β-induced iTregs were stimulated with anti-CD3/28 microbeads (5 cells per bead), IL-2 (50 U/mL) in standard media, or with additional 40 mM NaCl for 72 h, followed by co-cultured with enriched T cells labeled with CFSE in the presence of soluble anti-CD3 (0.025 μg/mL). Baseline indicates no addition of conditioned Treg subsets. CFSE dilution was detected by FACS after 3 days.\
(B) Histograms depict cellular suppression and are gated on CD8^+^ T cells (n = 5).\
(C) tTregs and iTregs were prepared from CD90.1^+^ Foxp3^+^ GFP knock-in mice and some of them were pre-treated by sodium chloride (40 mM). D90.2^+^CD4^+^CD25^−^CD62L^+^CD44^−^ naive T cells alone or together with the various Treg subsets were adoptively transferred into Rag1^−/−^ mice via i.p. injection. All mice were sacrificed at 35 days after the cell transfer, weight loss was analyzed for disease severity (6 mice in each group in one experiment). Body weight of the recipient mice was presented as a percentage of the initial weight.\
(D) Gross morphology of colons was shown.\
(E) The loss of Foxp3-GFP of the four sets were also compared in mLN, cells were gated on CD90.1^+^ cell. Representative results (mean ± SEM) from three independent experiments are shown.\
(F) The bar graph depicts a summary of the experiment (6 mice in each group in one experiment). Statistical analyses were performed using Student's t test and one-way ANOVA. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001; ns, not significant.](nihms-1521871-f0006){#F5}

![High Salt Does Not Affect the Differentiation and Function of Human iTreg Cells\
Human naive CD4^+^CD25^−^CD45RA^+^CD45RO^−^ cells were stimulated with anti-CD3/28 microbeads in the presence of rhIL-2 and TGF-β in standard media, or in the presence of an additional 20 or 40 mM NaCl for 5 days.\
(A) Foxp3 expression was detected by FACS.\
(B) The bar graph depicts a summary of independent experiments in A (n = 5).\
(C) T responder cells labeled with CFSE were stimulated with anti-CD3 in the presence of γ-irradiated antigen presenting cells (APCs). iTreg cells or iTregs primed with NaCl were added to culture wells. CFSE dilution and suppressive rates were calculated. Histograms depict cellular proliferation and are gated on CD8^+^ cells.\
(D) The bar graph depicts a summary of independent experiments in (C) (n = 5). Statistical analyses were performed using one-way ANOVA. ns, not significant.](nihms-1521871-f0007){#F6}

  REAGENT or RESOURCE                             SOURCE                      IDENTIFIER
  ----------------------------------------------- --------------------------- -------------------------------------------
  Antibodies                                                                  
  Percp/cy5.5 anti-mouse CD4 antibody             Biolegend                   Cat\# 100540; RRID: AB_893326
  PE anti-mouse CD25 antibody                     Biolegend                   Cat\# 101904; RRID: AB_312847
  APC anti-mouse CD62L antibody                   Biolegend                   Cat\# 104412; RRID: AB_313099
  PE/Cy7 anti-mouse/human CD44 antibody           Biolegend                   Cat\# 103030; RRID: AB_830787
  LEAF Purified anti-mouse CD3ε antibody          Biolegend                   Cat\# 100331; RRID: AB_1877073
  PE anti-mouse IL17A antibody                    Biolegend                   Cat\# 506904; RRID: AB_315464
  APC anti-mouse IFNγ antibody                    Biolegend                   Cat\# 505810; RRID: AB_315404
  APC anti-mouse CD8a antibody                    Biolegend                   Cat\# 100712; RRID: AB_312751
  GAPDH (D16H11) Rabbit mAb                       Cell Signaling Technology   Cat\# 5174; RRID: AB_10622025
  Phospho-FoxO1(Thr24)/FoxO3a(Thr32) Antibody     Cell Signaling Technology   Cat\# 9464; RRID: AB_329842
  Anti-Rabbit IgG, HRP-linked Antibody            Cell Signaling Technology   Cat\# 7074; RRID: AB_2099233
  Chemicals, Peptides, and Recombinant Proteins                               
  Recombinant Human IL-2 Protein                  R&D                         Cat\# 202-IL-050
  Recombinant Human TGF-β1 protein                R&D                         Cat\# 240-B
  Sodium chloride solution                        Sigma Aldrich               Cat\# S5150
  Brefeldin A                                     Sigma Aldrich               Cat\# B7651--5MG
  Ionomycin calcium salt                          Sigma Aldrich               Cat\# I0634--1MG
  Phorbol 12-myristate 13-acetate                 Sigma Aldrich               Cat\# P8139--1MG
  Dynabeads Mouse T-activator CD3/28              Thermo Fisher               Cat\# 11453D
  Dynabeads Human T-activator CD3/28              Thermo Fisher               Cat\# 11132D
  X-VIVO15                                        LONZA                       Cat\# 04--744Q
  Critical Commercial Assays                                                  
  CellTrace CFSE Cell proliferation kit           Thermo Fisher               Cat\# C34554
  Naive CD4^+^ T cell isolation kit, mouse        Miltenyi                    Cat\# 130--104--453
  Experimental Models: Organisms/Strains                                      
  Mouse: C57BL/6J                                 The Jackson Laboratory      Cat\# 000664
  Mouse: B6-Foxp3 ^GFP^                           The Jackson Laboratory      Cat\# 006772
  Mouse: Rag1 KO                                  The Jackson Laboratory      Cat\# 002216
  Software and Algorithms                                                     
  FlowJo                                          FlowJo, LLC                 <https://www.flowjo.com/solutions/flowjo>
  GraphPad Prism                                  GraphPad                    <https://www.graphpad.com/>
  Other                                                                       
  Sequence data, analyses.                        This paper                  N/A

###### Highlights

-   High salt restrains thymic regulatory T cell (tTreg) cell function

-   High salt does not affect induced Treg (iTreg) cell function

-   High salt promotes Th17 development via SGK1
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